Novelty Technology Care Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
106
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
3
- Investments
-
4
Novelty Technology Care General Information
Description
Manufacturer of pharmaceutical products, medical devices and food supplements based in Milan, Italy. The company is engaged in the research, development and production of drugs, innovative medical devices and high-quality food supplements that are sold worldwide through licensees and distributors and is involved in the development of products in ophthalmology, gastroenterology and women's health.
Contact Information
Website
www.ntcpharma.comCorporate Office
- Via Dei Gracchi, 35
- 20146 Milan
- Italy
Corporate Office
- Via Dei Gracchi, 35
- 20146 Milan
- Italy
Novelty Technology Care Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novelty Technology Care Patents
Novelty Technology Care Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3228374-A1 | Compound in the form of particles functionalized with high percentage ionic metal, and its use as an antimicrobial | Pending | 31-Aug-2021 | ||
| EP-4396192-A1 | Compound in the form of particles functionalized with high percentage ionic metal, and its use as an antimicrobial | Pending | 31-Aug-2021 | ||
| EP-4240364-A1 | Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof | Pending | 09-Nov-2020 | ||
| CA-3197797-A1 | Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof | Pending | 09-Nov-2020 | ||
| AU-2021375352-A1 | Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof | Pending | 09-Nov-2020 | A61P27/02 |
Novelty Technology Care Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Novelty Technology Care Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novelty Technology Care Investments (4)
Novelty Technology Care’s most recent deal was a Corporate Asset Purchase with NMTech (TiAb and SIAB Based Technology). The deal was made on 12-Jun-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NMTech (TiAb and SIAB Based Technology) | 12-Jun-2019 | Corporate Asset Purchase | Buildings and Property | ||
| NMTech UK (TiAb and SIAB Technologies) | 12-Jun-2019 | Buyout/LBO | Buildings and Property | ||
| Novartis (Portfolio of Ophthalmic Antibiotics) | 31-May-2018 | Buyout/LBO | Buildings and Property | ||
| PH&T | 01-Jan-2016 | Buyout/LBO | Pharmaceuticals |
Novelty Technology Care FAQs
-
When was Novelty Technology Care founded?
Novelty Technology Care was founded in 2014.
-
Where is Novelty Technology Care headquartered?
Novelty Technology Care is headquartered in Milan, Italy.
-
What is the size of Novelty Technology Care?
Novelty Technology Care has 106 total employees.
-
What industry is Novelty Technology Care in?
Novelty Technology Care’s primary industry is Pharmaceuticals.
-
Is Novelty Technology Care a private or public company?
Novelty Technology Care is a Private company.
-
What is Novelty Technology Care’s current revenue?
The current revenue for Novelty Technology Care is .
-
How much funding has Novelty Technology Care raised over time?
Novelty Technology Care has raised $16.2M.
-
Who are Novelty Technology Care’s investors?
Unigestion, Medeor Associates, and Wise Equity have invested in Novelty Technology Care.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
